{"entity":{"type":"insider","cik":"0001620152","url":"/insider/0001620152","json_url":"/insider/0001620152.json","name":"Bazemore Robert B","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":9,"first":"2019-06-14","last":"2021-04-01","span_basis":"filed_date"},"name_variants":[{"name":"Bazemore Robert B","source":"filing","n_filings":9,"first_seen":"2019-06-14","last_seen":"2021-04-01"}],"transactions":[{"id":5521598,"accession":"0001209191-21-024159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-024159","line_url":"/filing/0001209191-21-024159#line-1","is_derivative":false,"issuer_cik":"0001620152","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001620152","owner_cik":"0001620152","owner_name":"Bazemore Robert B","owner_display_name":"Bazemore Robert B","owner_url":"/insider/0001620152","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":9.9799,"price_display":"9.98","price_state":"stated","total_value":49899.5,"total_display":"49,899.50","total_whole":"49,900","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-30","filed_date":"2021-04-01","scope":"insider"},{"id":5318403,"accession":"0000899243-21-013804","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-013804","line_url":"/filing/0000899243-21-013804#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001620152","owner_name":"Bazemore Robert B","owner_display_name":"Bazemore Robert B","owner_url":"/insider/0001620152","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10328.0,"shares_display":"10,328","price_per_share":7.85,"price_display":"7.85","price_state":"stated","total_value":81074.8,"total_display":"81,074.80","total_whole":"81,075","shares_owned_after":322626.0,"shares_owned_after_display":"322,626","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-25","filed_date":"2021-03-29","scope":"insider"},{"id":4550053,"accession":"0000899243-21-005044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-005044","line_url":"/filing/0000899243-21-005044#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001620152","owner_name":"Bazemore Robert B","owner_display_name":"Bazemore Robert B","owner_url":"/insider/0001620152","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3890.0,"shares_display":"3,890","price_per_share":11.21,"price_display":"11.21","price_state":"stated","total_value":43606.9,"total_display":"43,606.90","total_whole":"43,607","shares_owned_after":331977.0,"shares_owned_after_display":"331,977","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-04","filed_date":"2021-02-05","scope":"insider"},{"id":5087515,"accession":"0000899243-21-003535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-003535","line_url":"/filing/0000899243-21-003535#line-1","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001620152","owner_name":"Bazemore Robert B","owner_display_name":"Bazemore Robert B","owner_url":"/insider/0001620152","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6069.0,"shares_display":"6,069","price_per_share":11.41,"price_display":"11.41","price_state":"stated","total_value":69247.29,"total_display":"69,247.29","total_whole":"69,247","shares_owned_after":248367.0,"shares_owned_after_display":"248,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-27","scope":"insider"},{"id":2287601,"accession":"0000899243-20-017904","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-017904","line_url":"/filing/0000899243-20-017904#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001620152","owner_name":"Bazemore Robert B","owner_display_name":"Bazemore Robert B","owner_url":"/insider/0001620152","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4773.0,"shares_display":"4,773","price_per_share":16.15,"price_display":"16.15","price_state":"stated","total_value":77083.95,"total_display":"77,083.95","total_whole":"77,084","shares_owned_after":250098.0,"shares_owned_after_display":"250,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-26","filed_date":"2020-06-30","scope":"insider"},{"id":2418834,"accession":"0000899243-20-017444","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-017444","line_url":"/filing/0000899243-20-017444#line-3","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001620152","owner_name":"Bazemore Robert B","owner_display_name":"Bazemore Robert B","owner_url":"/insider/0001620152","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":220000.0,"total_display":"220,000.00","total_whole":"220,000","shares_owned_after":254371.0,"shares_owned_after_display":"254,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-18","filed_date":"2020-06-22","scope":"insider"},{"id":2418830,"accession":"0000899243-20-017444","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-017444","line_url":"/filing/0000899243-20-017444#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001620152","owner_name":"Bazemore Robert B","owner_display_name":"Bazemore Robert B","owner_url":"/insider/0001620152","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":220000.0,"total_display":"220,000.00","total_whole":"220,000","shares_owned_after":244371.0,"shares_owned_after_display":"244,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-18","filed_date":"2020-06-22","scope":"insider"},{"id":2132589,"accession":"0000899243-20-009605","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-009605","line_url":"/filing/0000899243-20-009605#line-4","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001620152","owner_name":"Bazemore Robert B","owner_display_name":"Bazemore Robert B","owner_url":"/insider/0001620152","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3285.0,"shares_display":"3,285","price_per_share":15.28,"price_display":"15.28","price_state":"stated","total_value":50194.8,"total_display":"50,194.80","total_whole":"50,195","shares_owned_after":254371.0,"shares_owned_after_display":"254,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-25","filed_date":"2020-03-26","scope":"insider"},{"id":3194529,"accession":"0000899243-20-002113","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-002113","line_url":"/filing/0000899243-20-002113#line-3","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001620152","owner_name":"Bazemore Robert B","owner_display_name":"Bazemore Robert B","owner_url":"/insider/0001620152","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6074.0,"shares_display":"6,074","price_per_share":20.44,"price_display":"20.44","price_state":"stated","total_value":124152.56,"total_display":"124,152.56","total_whole":"124,153","shares_owned_after":84668.0,"shares_owned_after_display":"84,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-01-27","scope":"insider"},{"id":3194526,"accession":"0000899243-20-002113","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-002113","line_url":"/filing/0000899243-20-002113#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001620152","owner_name":"Bazemore Robert B","owner_display_name":"Bazemore Robert B","owner_url":"/insider/0001620152","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3002.0,"shares_display":"3,002","price_per_share":24.62,"price_display":"24.62","price_state":"stated","total_value":73909.24,"total_display":"73,909.24","total_whole":"73,909","shares_owned_after":90742.0,"shares_owned_after_display":"90,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-24","filed_date":"2020-01-27","scope":"insider"},{"id":8580752,"accession":"0000899243-19-017098","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-017098","line_url":"/filing/0000899243-19-017098#line-2","is_derivative":false,"issuer_cik":"0001571498","issuer_name":"Epizyme, Inc.","issuer_ticker":"EPZM","issuer_name_source":null,"issuer_url":"/issuer/0001571498","owner_cik":"0001620152","owner_name":"Bazemore Robert B","owner_display_name":"Bazemore Robert B","owner_url":"/insider/0001620152","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, par value $0.0001","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2074.0,"shares_display":"2,074","price_per_share":12.1,"price_display":"12.10","price_state":"stated","total_value":25095.4,"total_display":"25,095.40","total_whole":"25,095","shares_owned_after":84994.0,"shares_owned_after_display":"84,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-13","filed_date":"2019-06-14","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001811063","name":"Nuvation Bio Inc.","url":"/issuer/0001811063","role":"Director","n_filings":1,"first_seen":"2021-04-01","last_seen":"2021-04-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001571498","name":"Epizyme, Inc.","url":"/issuer/0001571498","role":"Director, Officer (President & CEO)","n_filings":8,"first_seen":"2019-06-14","last_seen":"2021-03-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001620152","retrieved_at":"2026-08-22T05:28:56+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}